Latest period
$4.08B
YoY change
+17.2%
5Y CAGR
+8.9%
Peak year (FY2025)
$4.27B
Latest annual
$4.27B
Total Assets history chart for West Pharmaceutical Services (WST) from 2016 to 2025
Latest: $4.27B
Total Assets growth chart for West Pharmaceutical Services (WST) from 2016 to 2025
Latest: +17.2%
Total Assets history table for West Pharmaceutical Services (WST) from 1985 to 2025
| FY2025 | $4.27B | +17.2% | +$627M | ||
| FY2024 | $3.64B | -4.9% | -$186M | ||
| FY2023 | $3.83B | +5.9% | +$213M | ||
| FY2022 | $3.62B | +9.1% | +$303M | ||
| FY2021 | $3.31B | +18.6% | +$520M | ||
| FY2020 | $2.79B | +19.3% | +$452M | ||
| FY2019 | $2.34B | +47.0% | +$749M | ||
| FY2018 | $1.59B | -14.5% | -$270M | ||
| FY2017 | $1.86B | +8.5% | +$146M | ||
| FY2016 | $1.72B | +1.3% | +$21.6M | ||
| FY2015 | $1.7B | +1.4% | +$24.2M | ||
| FY2014 | $1.67B | -0.0% | -$700K | ||
| FY2013 | $1.67B | +6.9% | +$108M | ||
| FY2012 | $1.56B | +11.8% | +$165M | ||
| FY2011 | $1.4B | +8.1% | +$105M | ||
| FY2010 | $1.29B | +1.8% | +$23.3M | ||
| FY2009 | $1.27B | +8.8% | +$102M | ||
| FY2008 | $1.17B | -1.4% | -$16.9M | ||
| FY2007 | $1.19B | +29.1% | +$267M | ||
| FY2006 | $918M | +11.5% | +$94.6M | ||
| FY2005 | $824M | +25.0% | +$165M | ||
| FY2004 | $659M | +5.6% | +$35.1M | ||
| FY2003 | $624M | +16.2% | +$86.8M | ||
| FY2002 | $537M | +5.0% | +$25.5M | ||
| FY2001 | $511M | -8.3% | -$46.1M | ||
| FY2000 | $557M | +1.0% | +$5.6M | ||
| FY1999 | $552M | +9.1% | +$46.2M | ||
| FY1998 | $506M | +5.8% | +$27.7M | ||
| FY1997 | $478M | +0.1% | +$500K | ||
| FY1996 | $477M | -0.6% | -$2.7M | ||
| FY1995 | $480M | +20.8% | +$82.7M | ||
| FY1994 | $397M | +29.3% | +$90M | ||
| FY1993 | $307M | +1.0% | +$3M | ||
| FY1992 | $304M | -2.8% | -$8.8M | ||
| FY1991 | $313M | -8.8% | -$30.3M | ||
| FY1990 | $344M | +9.7% | +$30.5M | ||
| FY1989 | $313M | +4.7% | +$14.1M | ||
| FY1988 | $299M | +6.7% | +$18.8M | ||
| FY1987 | $280M | +18.0% | +$42.7M | ||
| FY1986 | $237M | +32.6% | +$58.4M | ||
| FY1985 | $179M | — | — |
- FY2025$4.27B+17.2%
- FY2024$3.64B-4.9%
- FY2023$3.83B+5.9%
- FY2022$3.62B+9.1%
- FY2021$3.31B+18.6%
- FY2020$2.79B+19.3%
- FY2019$2.34B+47.0%
- FY2018$1.59B-14.5%
- FY2017$1.86B+8.5%
- FY2016$1.72B+1.3%
- FY2015$1.7B+1.4%
- FY2014$1.67B-0.0%
- FY2013$1.67B+6.9%
- FY2012$1.56B+11.8%
- FY2011$1.4B+8.1%
- FY2010$1.29B+1.8%
- FY2009$1.27B+8.8%
- FY2008$1.17B-1.4%
- FY2007$1.19B+29.1%
- FY2006$918M+11.5%
- FY2005$824M+25.0%
- FY2004$659M+5.6%
- FY2003$624M+16.2%
- FY2002$537M+5.0%
- FY2001$511M-8.3%
- FY2000$557M+1.0%
- FY1999$552M+9.1%
- FY1998$506M+5.8%
- FY1997$478M+0.1%
- FY1996$477M-0.6%
- FY1995$480M+20.8%
- FY1994$397M+29.3%
- FY1993$307M+1.0%
- FY1992$304M-2.8%
- FY1991$313M-8.8%
- FY1990$344M+9.7%
- FY1989$313M+4.7%
- FY1988$299M+6.7%
- FY1987$280M+18.0%
- FY1986$237M+32.6%
- FY1985$179M—
Total Assets values are taken from West Pharmaceutical Services's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's latest reported total assets is $4.08B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, West Pharmaceutical Services (WST) total assets totalled $4.27B – grew 17.2% year-over-year.
Through 2020–2025 (5 years), West Pharmaceutical Services total assets delivered a +8.9% annualised rate; with mixed annual results across the window.
Across the available history, total assets reached its high of $4.27B in 2025 and its low of $179M in 1985.
West Pharmaceutical Services Total Assets by Year
West Pharmaceutical Services Total Assets 2025: $4.27B
2025's total assets for West Pharmaceutical Services came in at $4.27B, grew 17.2% from 2024. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Total Assets 2024: $3.64B
West Pharmaceutical Services posted total assets of $3.64B in 2024, edged down 4.9% below 2023.
West Pharmaceutical Services Total Assets 2023: $3.83B
In 2023, West Pharmaceutical Services reported total assets of $3.83B, grew 5.9% from 2022.
West Pharmaceutical Services Total Assets 2022: $3.62B
West Pharmaceutical Services total assets in 2022 was $3.62B, grew 9.1% from 2021.
West Pharmaceutical Services Total Assets 2021: $3.31B
West Pharmaceutical Services total assets in 2021 was $3.31B.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by Total Assets
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest total assets
| $310B | |
| $199B | |
| $137B | |
| $134B | |
| $112B | |
| $110B | |
| $90.6B | |
| $85.4B |
- $137B
- $134B
- $112B
- $90.6B
- $85.4B
Frequently asked questions
Test yourself on WST
Market Cap — 10 rounds, every one of them WST against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.34% TTM
- Dividend Profile0.32% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.